Briya vs CytoReason
Briya vs CytoReason, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Briya is on 56/100 and CytoReason on 68/100.
Where each one leads
Briya
- agent readiness: 39/100 against 21/100
- headcount growth: +24.5% against +13.7%
CytoReason
- our overall score: 68/100 against 56/100
- domain rating: 40/100 against 26/100
- headcount: 116 against 62
- funding raised: $128M against $17.0M
- LinkedIn following: 12,830 against 4,564
At a glance
| Measure | Briya | CytoReason |
|---|---|---|
| What it is | Platform for real-time retrieval and sharing of harmonized longitudinal clinical data. | Develops a computational model of the human body for drug discovery and development. |
| Category | Healthcare, Data, Blockchain, Data Platform | Healthcare, Drug Discovery, Clinical Development, Biomarkers |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2020 | 2016 |
| Headquarters | New York, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Briya | CytoReason |
|---|---|---|
| Employees | 62 | 116 |
| Headcount growthLast 12 months | +24.5% | +13.7% |
| Total funding | $17.0M | $128M |
| Latest round | Series A | Series B |
| LinkedIn followers | 4,564 | 12,830 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Briya | CytoReason |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 68/100 |
| Traction | 54/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Community | 8/100 | Not published |
| Search visibility | 30/100 | 30/100 |
| Quality | 58/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 26/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Briya | CytoReason |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Not detected | Segment |
| Support stack | HubSpot | Not detected |
Briya vs CytoReason: common questions
Which is better, Briya or CytoReason?
On our 0-100 score CytoReason rates higher (68/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Briya and CytoReason compare on the numbers?
Briya leads on agent readiness (39/100 against 21/100), headcount growth (+24.5% against +13.7%). CytoReason leads on our overall score (68/100 against 56/100), domain rating (40/100 against 26/100), headcount (116 against 62), funding raised ($128M against $17.0M), LinkedIn following (12,830 against 4,564).
Read the full Briya review and pricing or the CytoReason review and pricing. You can also browse other Briya alternatives we track.